World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
44
Citations
9976
World Ranking
4758
National Ranking
181

Kazunari Yamaguchi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Kazunari Yamaguchi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 197 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Kazunari Yamaguchi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Kazunari Yamaguchi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Kazunari Yamaguchi is affiliated with the National Institute of Infectious Diseases, Tokyo in Japan. Their work is connected to this institution, which focuses on research in infectious diseases and related biomedical sciences.

As an active researcher, Kazunari Yamaguchi has not published recent papers indexed in the data provided. There are no records of co-authors or frequent publication venues associated with their work in the available information.

There is also no data on book publications or main and subfields of study linked to this scientist. Similarly, no specific topics of research or awards have been recorded.

Given the absence of detailed publication and collaboration records, it is likely that their research contributions remain within specialized or institutional domains that have not been extensively documented in the databases queried.

Best Publications

  • Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease.

    M Yoshida;M Seiki;K Yamaguchi;K Takatsuki

  • VCAP-AMP-VECP Compared With Biweekly CHOP for Adult T-Cell Leukemia-Lymphoma: Japan Clinical Oncology Group Study JCOG9801

    Kunihiro Tsukasaki;Atae Utsunomiya;Haruhiko Fukuda;Taro Shibata

  • Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting

    Kunihiro Tsukasaki;Olivier Hermine;Ali Bazarbachi;Lee Ratner

  • Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma

    Kazuhito Yamamoto;Atae Utsunomiya;Kensei Tobinai;Kunihiro Tsukasaki

  • Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan.

    Masako Iwanaga;Masako Iwanaga;Toshiki Watanabe;Atae Utsunomiya;Akihiko Okayama

  • HTLV-I uveitis: a distinct clinical entity caused by HTLV-I.

    Manabu Mochizuki;Toshiki Watanabe;Kazunari Yamaguchi;Kiyoshi Takatsuki

  • Adult T-Cell Leukemia: A Review of Epidemiological Evidence

    Masako Iwanaga;Toshiki Watanabe;Kazunari Yamaguchi

  • Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.

    Masahiro Satake;Kazunari Yamaguchi;Kenji Tadokoro

  • Persistent Clonal Proliferation of Human T-lymphotropic Virus Type I-infected Cells in Vivo

    Ken-ichiro Etoh;Sadahiro Tamiya;Kazunari Yamaguchi;Akihiko Okayama

  • Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis

    K. Nakada;K. Yamaguchi;K. Yamaguchi;S. Furugen;T. Nakasone

  • Clinical diversity in adult T-cell leukemia-lymphoma.

    Kiyoshi Takatsuki;Kazunari Yamaguchi;Fumio Kawano;Toshio Hattori

  • Dual targeting of transformed and untransformed HTLV-1–infected T cells by DHMEQ, a potent and selective inhibitor of NF-κB, as a strategy for chemoprevention and therapy of adult T-cell leukemia

    Mariko Watanabe;Takeo Ohsugi;Momoko Shoda;Takaomi Ishida

  • Hepatitis C virus antibodies in haemodialysis patients

    U Schlipköter;M Roggendorf;G Ernst;R Rasshofer

  • Pulmonary complications in patients with adult T-cell leukemia

    Ritsuko Yoshioka;Kazunari Yamaguchi;Takeshi Yoshinaga;Kiyoshi Takatsuki

  • A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction

    Shigeki Takemoto;Masao Matsuoka;Kazunari Yamaguchi;Kiyoshi Takatsuki

  • Hypercalcemia and osteoclast proliferation in adult T‐cell leukemia

    Tetsuyuki Kiyokawa;Kazunari Yamaguchi;Motohiro Takeya;Kiyoshi Takahashi

  • Polyclonal integration of HTLV-I proviral DNA in lymphocytes from HTLV-I seropositive individuals : An intermediate state between the healthy carrier state and smouldering ATL

    Kazunari Yamaguchi;Kazunari Yamaguchi;Tetsuyuki Kiyokawa;Kiyonobu Nakada;Lee Song Yul

  • Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis

    Masao Satoh;Hiromu Toma;Kazuyuki Sugahara;Ken-ichiro Etoh

  • Clinical evaluation of calcium metabolism in adult T-cell leukemia/lymphoma.

    Seiji Fukumoto;Toshio Matsumoto;Kyoji Ikeda;Takayuki Yamashita

  • HTLV-I seroprevalence in patients with malignancy.

    Norio Asou;Takashi Kumagai;Soichi Uekihara;Masao Ishii

  • Serum levels of soluble IL‐2 receptor, IL‐4 and IgE‐binding factors in childhood allergic diseases

    Unknown

  • Human T lymphotropic virus type 1 uveitis after Graves' disease.

    K Yamaguchi;M Mochizuki;T Watanabe;K Yoshimura

  • In vivo antitumor activity of the NF-κB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia

    Takeo Ohsugi;Ryouichi Horie;Toshio Kumasaka;Akira Ishida

  • Rapid quantification of HTLV-I provirus load: detection of monoclonal proliferation of HTLV-I-infected cells among blood donors.

    Ken-ichiro Etoh;Kazunari Yamaguchi;Shinkan Tokudome;Toshiki Watanabe

Frequent Co-Authors

Kiyoshi Takatsuki
Kiyoshi Takatsuki Kumamoto University
Toshiki Watanabe
Toshiki Watanabe University of Tokyo
Manabu Mochizuki
Manabu Mochizuki Tokyo Medical and Dental University
Masao Matsuoka
Masao Matsuoka Kumamoto University
Atae Utsunomiya
Atae Utsunomiya Kagoshima University
Shimeru Kamihira
Shimeru Kamihira Nagasaki University
Kazuo Tajima
Kazuo Tajima Kagoshima University
Seishi Ogawa
Seishi Ogawa Kyoto University
Hiroaki Mitsuya
Hiroaki Mitsuya Kumamoto University
Nobuo Nomura
Nobuo Nomura National Institute of Advanced Industrial Science and Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can enhance career opportunities. Many professionals transition into specialized areas through programs like the fnp to acnp bridge program online, which helps Family Nurse Practitioners shift into Acute Care roles. This path builds advanced clinical knowledge particularly useful in immunology-related patient care.

Nurses looking to advance quickly may consider accelerated RN to NP programs. These programs short-cut traditional pathways, allowing registered nurses to become Nurse Practitioners in a shorter timeframe. The accelerated rn to np programs offer an efficient route for professionals eager to specialize further in immunology or related fields.

Those without a nursing background are not left behind; there are accessible options like online rn programs for non nurses that open doors to foundational nursing degrees. These programs provide a strong base to then pursue advanced immunology-focused roles.

Additionally, students seeking entry-level nursing education might explore the easiest absn program to get into. Accelerated BSN programs offer a practical, high-quality route to start a career that could lead into immunology research and clinical practice.

Best Scientists Citing Kazunari Yamaguchi

Trending Scientists

Recently Published Articles